论文部分内容阅读
目的观察经皮穴位敷贴给药联合布地奈德雾化吸入治疗儿童支原体肺炎后咳嗽的疗效。方法将82例支原体肺炎后咳嗽患儿随机分为对照组和治疗组,各41例。对照组给予阿奇霉素口服及布地奈德雾化吸入治疗,治疗组在对照组治疗方法的基础上给予平喘止咳贴(苗药巴布剂)经皮穴位敷贴。治疗7 d后,比较2组的临床疗效和治疗前、后各时间点咳嗽评分变化。结果治疗组总有效率为97.6%,对照组为87.8%,2组比较差异有高度统计意义(P<0.01);治疗组治疗3,5,7 d后咳嗽评分分别为(1.66±0.61),(1.13±0.50),(0.41±0.17)分,均低于对照组的(2.11±0.58),(1.72±0.53),(0.98±0.42)分,差异均有高度统计意义(P<0.01)。结论平喘止咳贴辅助治疗儿童支原体肺炎后咳嗽可显著改善患儿的临床症状,疗效确切。
Objective To observe the curative effect of transdermal application of acupuncture combined with budesonide inhalation on children with mycoplasma pneumonia. Methods 82 cases of children with mycoplasma pneumonia after cough were randomly divided into control group and treatment group, 41 cases each. The control group was given azithromycin orally and budesonide inhalation therapy, the treatment group in the control group based on the treatment of asthma cough paste (Miao drug cataplasm) transdermal application. After 7 days of treatment, the clinical efficacy of the two groups were compared and the changes of cough scores at each time point before and after treatment were compared. Results The total effective rate was 97.6% in the treatment group and 87.8% in the control group. The differences between the two groups were statistically significant (P <0.01). The cough scores of the treatment group after treatment were respectively (1.66 ± 0.61), (1.13 ± 0.50) and (0.41 ± 0.17) points respectively, which were significantly lower than those of the control group (2.11 ± 0.58), (1.72 ± 0.53) and (0.98 ± 0.42) points, respectively. Conclusion Anti-asthma cough paste assisted treatment of children with mycoplasma pneumonia after cough can significantly improve the clinical symptoms of children, the exact effect.